Reach in a pragmatic hypertension trial: A critical RE-AIM component.
JaKa M, Bergdall A, Beran MS, Solberg L, Green BB, Andersen J, Kodet A, Norman S, Haugen P, Crain L, Trower N, Sharma R, Rehrauer D, Maeztu C, Margolis K.
JaKa M, et al. Among authors: green bb.
Contemp Clin Trials. 2022 Oct;121:106896. doi: 10.1016/j.cct.2022.106896. Epub 2022 Aug 24.
Contemp Clin Trials. 2022.
PMID: 36029952